InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Gentile Kimberly, Chief Operating Officer. Officer active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 4 reports have been published. The latest transaction was filed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
03,750 shares0
Common Shares
SEC:0001562180-22-000354·
03,750 shares0
Common Shares
SEC:0001562180-22-000354:0·
03,750 shares0
Common Shares
SEC:0001562180-21-007301·
03,750 shares0
Common Shares
SEC:0001562180-21-007301:0·
4 of 4 declarations
About Gentile Kimberly
Kimberly Gentile is the Senior Vice President of Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd. She oversees clinical operations and the development of new treatments. Her expertise in clinical research is essential for the success of the company's initiatives. Kimberly is committed to improving patient outcomes through innovative solutions.
